» Articles » PMID: 26886597

Atorvastatin Use Associated With Acute Pancreatitis: A Case-Control Study in Taiwan

Overview
Specialty General Medicine
Date 2016 Feb 18
PMID 26886597
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Few data are present in the literature on the relationship between atorvastatin use and acute pancreatitis. The aim of this study was to explore this issue in Taiwan. Using representative claims data established from the Taiwan National Health Insurance Program, this case-control study consisted of 5810 cases aged 20 to 84 years with a first-time diagnosis of acute pancreatitis during the period 1998 to 2011and 5733 randomly selected controls without acute pancreatitis. Both cases and controls were matched by sex, age, comorbidities, and index year of diagnosing acute pancreatitis. Subjects who at least received 1 prescription for other statins or nonstatin lipid-lowering drugs were excluded from the study. If subjects never had 1 prescription for atorvastatin, they were defined as never use of atorvastatin. Current use of atorvastatin was defined as subjects whose last remaining 1 tablet of atorvastatin was noted ≤7 days before the date of diagnosing acute pancreatitis. Late use of atorvastatin was defined as subjects whose last remaining 1 tablet of atorvastatin was noted >7 days before the date of diagnosing acute pancreatitis. The odds ratio with 95% confidence interval of acute pancreatitis associated with atorvastatin use was calculated by using the logistic regression analysis. The logistic regression analysis revealed that the odds ratio of acute pancreatitis was 1.67 for subjects with current use of atorvastatin (95% confidence interval 1.18, 2.38), when compared with subjects with never use of atorvastatin. The odds ratio decreased to 1.15 for those with late use of atorvastatin (95% confidence interval 0.87, 1.52), but without statistical significance. Current use of atorvastatin is associated with the diagnosis of acute pancreatitis. Clinically, clinicians should consider the possibility of atorvastatin-associated acute pancreatitis when patients present with a diagnosis of acute pancreatitis without a definite etiology but are taking atorvastatin.

Citing Articles

Evaluating the Protective Effect of Melatonin on Atorvastatin-induced Mitochondrial Toxicity in Pancreatic Beta Cells.

Mehrzadi S, Hosseini A, Hosseinzadeh A Curr Drug Saf. 2024; 19(4):455-464.

PMID: 39188214 DOI: 10.2174/0115748863267262231025052412.


A Drug-Induced Acute Pancreatitis Retrospective Study.

Gagnon A, Lavoie A, Frigon M, Michaud-Herbst A, Tremblay K Can J Gastroenterol Hepatol. 2020; 2020:1516493.

PMID: 33204673 PMC: 7655261. DOI: 10.1155/2020/1516493.


No association between losartan use and acute pancreatitis in hypertensive patients.

Lai S, Lin H, Lin C, Liao K Eur J Hosp Pharm. 2019; 24(2):120-123.

PMID: 31156917 PMC: 6451466. DOI: 10.1136/ejhpharm-2015-000840.


Statin use is not associated with an increased risk of acute pancreatitis-A meta-analysis of observational studies.

Poropat G, Archibugi L, Korpela T, Cardenas-Jaen K, de-Madaria E, Capurso G United European Gastroenterol J. 2018; 6(8):1206-1214.

PMID: 30288283 PMC: 6169058. DOI: 10.1177/2050640618781168.


Case of familial hyperlipoproteinemia type III hypertriglyceridemia induced acute pancreatitis: Role for outpatient apheresis maintenance therapy.

Saleh M, Mansoor E, Cooper G World J Gastroenterol. 2017; 23(40):7332-7336.

PMID: 29142480 PMC: 5677204. DOI: 10.3748/wjg.v23.i40.7332.


References
1.
Lai S, Muo C, Liao K, Sung F, Chen P . Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol. 2011; 106(9):1697-704. DOI: 10.1038/ajg.2011.155. View

2.
Miltiadous G, Anthopoulou A, Elisaf M . Acute pancreatitis possibly associated with combined salicylate and atorvastatin therapy. JOP. 2003; 4(1):20-1. View

3.
Athyros V, Tziomalos K, Karagiannis A, Mikhailidis D . Atorvastatin: safety and tolerability. Expert Opin Drug Saf. 2010; 9(4):667-74. DOI: 10.1517/14740338.2010.495385. View

4.
Prajapati S, Shah S, Desai C, Desai M, Dikshit R . Atorvastatin-induced pancreatitis. Indian J Pharmacol. 2011; 42(5):324-5. PMC: 2959220. DOI: 10.4103/0253-7613.70400. View

5.
Singh S, Nautiyal A, Dolan J . Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect?. JOP. 2004; 5(6):502-4. View